Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Veedma Introduces a $59 Men's Lab Panel With 65 Biomarkers and a Doctor's Video Visit


News provided by

Veedma

Oct 13, 2026, 09:00 ET

Share this article

Share toX

Share this article

Share toX

Veedma, a preventive telehealth clinic for hormone and sexual health, has introduced two men's lab panels and a flat-price membership: a new patient's first 65-biomarker panel costs $59, including the Quest Diagnostics blood draw, a written report and a video visit with a licensed doctor.

SAN FRANCISCO, Oct. 13, 2026 /PRNewswire-PRWeb/ -- Veedma, a preventive telehealth clinic for hormone and sexual health, has introduced two men's lab panels and a new flat-price membership. A new patient's first Men's Optimal Health Lab Test costs $59 and covers 65 biomarkers, the blood draw at Quest Diagnostics, a written report from Veedma's medical team and a video visit with a licensed doctor, who reviews the findings together with the patient's symptoms and medical history before treatment is considered.

Veedma has always started care with laboratory testing, for two reasons. The first is diagnosis. Fatigue, low mood, reduced libido, weight gain and poor concentration are often attributed to low testosterone, yet the same symptoms can come from thyroid disease, insulin resistance, iron deficiency, low vitamin D or sleep apnea, and a single testosterone number cannot tell these causes apart. The new panels measure that broader picture from the first blood draw.

The second is the treatment decision itself. Measured alongside testosterone, the pituitary hormones LH and FSH show whether a man's testes have stopped responding or whether the signal that drives them is what is low. In the European Male Ageing Study, published in the Journal of Clinical Endocrinology and Metabolism in 2010, about 86% of men with low testosterone had the second pattern: the testes still worked, and the signal was the problem. For these men the first step can be aimed at the signal or at its cause, such as excess weight, a thyroid or prolactin disorder, a suppressing medication, or treatment that restarts the body's own production. Testosterone replacement switches that signal off, and with it the testes' own output and sperm production, so Veedma's doctors keep it as the option for men whose findings call for it.

The Optimal panel includes Total and Free Testosterone measured by LC-MS/MS with equilibrium dialysis, estradiol, LH, FSH, PSA, a complete blood count, liver, kidney and electrolyte panels, cholesterol and blood sugar. Its regular price is $89; Veedma bills labs at what the laboratory charges and takes $30 off the first panel. The Men's Biohacking Lab Test, at $409, covers 103 biomarkers and adds thyroid function and antibodies, fasting insulin and HbA1c, ApoB, hsCRP, iron studies, vitamin D, B12, prolactin, DHEA-S and heavy metals, among others. Both prices include the blood draw at Quest Diagnostics, a written report from Veedma's medical team, and a video visit with a licensed doctor. Lab panels are FSA and HSA eligible.

Men who already have recent blood work do not need to buy a panel. Results from any laboratory drawn within the past 180 days can be uploaded at https://veedma.com/ for a free clinical review. The written report is typically returned within 24 hours on business days and within 48 hours on weekends and holidays. No credit card is required.

When the report shows a treatment path, the patient chooses a membership plan and books a video visit with a licensed doctor. The card is saved without a charge, and the plan activates only when the doctor issues a prescription. A doctor's prescription is required for every medication Veedma provides. Membership is one flat price for any dose: $79 per month on an annual plan, $129 per month on a quarterly plan, or $159 per month with no commitment. It includes prescribed daily medication, the first video visit, follow-up reviews of lab results and dose adjustments, unlimited messaging with the care team, and delivery from Veedma's NABP-accredited partner pharmacy. Lab panels are chosen separately from the membership.

Whichever path the doctor chooses, patients on treatment have their labs rechecked after the first month and every six months after that, and hematocrit and PSA are checked before treatment and on every follow-up panel. Veedma's protocols follow guidance from the American Urological Association, the American Association of Clinical Endocrinology and the Endocrine Society.

About Veedma

Veedma is a preventive telehealth clinic for hormone and sexual health. Care starts with lab testing: licensed doctors find the cause of the symptoms before treating them. Veedma is LegitScript-certified: https://www.legitscript.com/websites/?checker_keywords=veedma.com. More at https://veedma.com/.

Media Contact

Victor Kuznetsov, Veedma, 1 4157924743, [email protected], https://veedma.com/

SOURCE Veedma

Modal title

Veedma logo
Veedma logo
Veedma logo

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.